DETECTION BY PROTON NUCLEAR MAGNETIC RESONANCE OF ELEVATED LACTATE CONCENTRATION IN SERUMS FROM PATIENTS WITH MALIGNANT TUMORS-Reference-Cited by-同舟云学术

DETECTION BY PROTON NUCLEAR MAGNETIC RESONANCE OF ELEVATED LACTATE CONCENTRATION IN SERUMS FROM PATIENTS WITH MALIGNANT TUMORS

Published:1979 Issue:5 Volume:32 Page:305-309
ISSN:0021-5112
Container-title:Japanese Journal of Medical Science and Biology
language:en
Short-container-title:JJMSB

Author:

OHSAKA AKIRA,YOSHIKAWA KENICHI,MATUHASI TYOKU

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

General Biochemistry, Genetics and Molecular Biology

Reference10 articles.

1. CORI, C. F. AND CORI, G. T. (1925) : The carbohydrate metabolism of tumors. 1. The free sugar, lactic acid, and glycogen content of malignant tumors. J. Biol. Chem., 64, 11-22.

2. DAMADIAN, R. (1971) : Tumor detection by nuclear magnetic resonance. Science, 171, 1151-1153.

3. HAUG, H. AND SCHRAMM, C. (1975) : Metabolic pattern of free amino acids, glucose, lactic acid, pyruvic acid, fatty acids, BUN, uric acid, etc. in serum of 21 healthy persons and 24 patients with malignant tumors. Clin Chem., 21, 1025.

4. HOLLIS, D. P., NUNNALLY, R. L., TAYLER, IV, G. J., WEISFELDT, M. L. AND JACOBUS, W. E. (1978) : Phosphorus nuclear magnetic resonance studies of heart physiology. J. Magn. Resonance, 29, 319-330.

5. JAMES, T. L. (1975) : Nuclear Magnetic Resonance in Biochemistry. Acad. Press, New York, 413p.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NMR spectroscopy at high magnetic fields: Derivative reconstructions of components from envelopes using encoded time signals;Advances in Quantum Chemistry;2022

2. Introduction;NMR Metabolomics in Cancer Research;2013

3. The application of NMR-based metabonomics in neurological disorders;NeuroRX;2006-07

4. A robust clustering approach for NMR spectra of natural product extracts;Magnetic Resonance in Chemistry;2005

5. Serum and Bile Markers for Cholangiocarcinoma;Seminars in Liver Disease;2004-06-11